Swiss pharmaceutical giant Novartis will pay some $729 million to settle a lawsuit brought by Washington accusing it of paying kickbacks to doctors, among other allegations.
Jul 2, 2020
0
6
GlaxoSmithKline said on Thursday it had agreed to pay $3.0 billion (2.2 billion euros) to settle long-running disputes with the US government over how the British pharmaceuticals group marketed and developed drugs.
Nov 3, 2011
0
0
(AP) -- The Department of Justice said Tuesday that drugmaker Merck will pay $950 million to resolve investigations into its marketing of the painkiller Vioxx.
Nov 22, 2011
0
0
People with intellectual and developmental disabilities experience sexual assault, abuse, violence and are victims of crime at exponentially higher rates than the typically developing population. Yet there are few abuse prevention ...
Jan 29, 2021
0
6
Early in the morning of Feb. 21, Change Healthcare, a company unknown to most Americans that plays a huge role in the U.S. health system, issued a brief statement saying some of its applications were "currently unavailable."
Mar 4, 2024
0
1
British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company's blood thinner Brilinta, and plans no further action.
Aug 19, 2014
0
0
More than 1 in 4 children have been exposed to physical violence between their parents at some time, 1 in 9 of them during the past year, according to new research from the University of New Hampshire Crimes against Children ...
Oct 17, 2011
0
0
The U.S. Justice Department said Tuesday that drugmaker Pfizer Inc. will pay almost $491 million to resolve an investigation into illegal marketing of the organ transplant drug Rapamune by a company Pfizer later acquired.
Jul 30, 2013
0
0
(AP)—The U.S. government is asking a federal appeals court to rehear a challenge to a requirement that tobacco companies to put large graphic health warnings on cigarette packages.
Oct 9, 2012
0
0
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
May 25, 2013
2
0
